OneSkin Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7M

  • Investors
  • 13

OneSkin General Information

Description

Provider of a topical skin supplement intended to target the root causes of skin aging. The company offers vegan supplements, made with ingredients that are suitable for all skin types, help to reduce the skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity, and strengthening the epidermal skin barrier, enabling customers to improve their skin and support proper cell function.

Contact Information

Website
www.oneskin.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (415)
Primary Industry
Personal Products
Vertical(s)
LOHAS & Wellness, Beauty, E-Commerce, Life Sciences
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (415)

OneSkin Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OneSkin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 01-Oct-2024 $7M Completed Generating Revenue
4. Seed Round 26-Oct-2022 Completed Generating Revenue
3. Seed Round 21-May-2017 Completed Generating Revenue
2. Accelerator/Incubator $200K Completed Startup
1. Accelerator/Incubator 14-Mar-2016 $200K $200K Completed Startup
To view OneSkin’s complete valuation and funding history, request access »

OneSkin Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed-3
Seed-2
Seed-1 833,422 $0.000010 $4.3 $4.3 1x $4.3 6.31%
Seed 2,628,424 $0.000010 $1 $1 1x $1 19.89%
To view OneSkin’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OneSkin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a topical skin supplement intended to target the root causes of skin aging. The company offers vegan supplem
Personal Products
San Francisco, CA
30 As of 2024

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OneSkin Competitors (1)

One of OneSkin’s competitors is Augustinus Bader, a Private Equity-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Augustinus Bader Private Equity-Backed London, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

OneSkin Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

OneSkin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202200959-D0 Polypeptides having anti-senescent effects and uses thereof Active 22-Jul-2019
GB-2603645-A Polypeptides having anti-senescent effects and uses thereof Active 22-Jul-2019
GB-2603645-B Polypeptides having anti-senescent effects and uses thereof Active 22-Jul-2019
US-20210038729-A1 Polypeptides having anti-senescent effects and uses thereof Active 22-Jul-2019
EP-4004021-A2 Polypeptides having anti-senescent effects and uses thereof Pending 22-Jul-2019 A61K38/08
To view OneSkin’s complete patent history, request access »

OneSkin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OneSkin Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Able Partners Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Plus Capital Venture Capital Minority
Unilever Ventures Corporate Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

OneSkin FAQs

  • When was OneSkin founded?

    OneSkin was founded in 2016.

  • Where is OneSkin headquartered?

    OneSkin is headquartered in San Francisco, CA.

  • What is the size of OneSkin?

    OneSkin has 30 total employees.

  • What industry is OneSkin in?

    OneSkin’s primary industry is Personal Products.

  • Is OneSkin a private or public company?

    OneSkin is a Private company.

  • What is the current valuation of OneSkin?

    The current valuation of OneSkin is .

  • What is OneSkin’s current revenue?

    The current revenue for OneSkin is .

  • How much funding has OneSkin raised over time?

    OneSkin has raised $21.6M.

  • Who are OneSkin’s investors?

    Able Partners, , , Plus Capital, and Unilever Ventures are 5 of 13 investors who have invested in OneSkin.

  • Who are OneSkin’s competitors?

    Augustinus Bader is a competitor of OneSkin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »